Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Hepatitis C Clinical Trials

56 recruiting trials for Hepatitis C. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
56
Total Trials
56
Recruiting Now
2
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT05361603

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program,...

Sponsor: University Hospital, LimogesEnrolling: 15001 location
RECRUITINGNCT05390424

Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot

The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users

Sponsor: University Hospital, RouenEnrolling: 50011 locations
RECRUITINGNCT04525833

Liver Disease and Other Systemic Diseases

Examine the association of chronic liver diseases (including hepatitis B, hepatitis C, alcoholic liver disease, fatty liver, liver cirrhosis, and hepatocellular carcinoma) with...

Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationEnrolling: 150001 location
RECRUITINGNCT03025074

Blood Collection Biorepository for Liver Disease Research

The purpose of establishing a biorepository is to provide high quality specimens (serum, plasma, buffy coat and liver tissue) for future researchers who are studying the effects...

Sponsor: State University of New York at BuffaloEnrolling: 10001 location
RECRUITINGNCT02995252

The HOPE Study: Characterizing Patients With Hepatitis B and C

This is an observational, longitudinal, prospective study for sample collection and evaluation for future therapy or disease progression of chronic hepatitis B and C. Participants...

Sponsor: University of Maryland, BaltimoreEnrolling: 5502 locations
RECRUITINGNCT05713136

The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset

The goal of this observational study is to learn if offering a point-of-care screening test for exposure to the Hepatitis C virus, before providing a diagnostic test for Hepatitis...

Sponsor: Kirby InstituteEnrolling: 4000012 locations
RECRUITINGNCT06431945

Early Detection of HCV in Injection Drug Users

The project is a national, prospective, multicenter, non-interventional pilot project of screening HCV in PWID in the Czech Republic. The main goal of the project is to...

Sponsor: Institute of Health Information and Statistics of the Czech RepublicEnrolling: 300018 locations
RECRUITINGNCT06367465

Feasibility and Acceptability of HCV Treatment in Pregnancy

Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH...

Sponsor: Washington University School of MedicineEnrolling: 502 locations
RECRUITINGNCT01644903

Proteogenomic Monitoring and Assessment of Liver Transplant Recipients

This study is being done to test blood, urine and tissue samples to see if this can help decide if CKD (Chronic Kidney Disease), AR (Acute Rejection) and HCV (Hepatitis C Virus)...

Sponsor: Northwestern UniversityEnrolling: 10001 location
RECRUITINGNCT06463912

Screening for Hepatitis c in People Who Inject Drugs in Armenia-Colombia

Hepatitis C virus infection is a major cause of chronic hepatitis, cirrhosis, and liver cancer. The risk of developing cirrhosis for people with chronic infection with the virus...

Sponsor: Asociación Colombiana de HepatologíaEnrolling: 2051 location
RECRUITINGNCT05751889

Serious Game Interventions to Reduce Viral Hepatitis C Among PLWH-MSM

The study is aimed to provide high-risk, HIV-infection, men who have sex with men (MSM) with healthcare education regarding viral hepatitis C, through either serious game...

Sponsor: National Taiwan University HospitalEnrolling: 13201 location
RECRUITINGPhase 4NCT06953479

Implementing Low-Barrier HCV Treatment in a Jail Setting

The goal of this clinical trial is to learn whether a low-barrier treatment program can help people with hepatitis C virus (HCV) who are in jail start and complete treatment more...

Sponsor: LifespanEnrolling: 401 location
RECRUITINGNCT04943588

Treating Hepatitis C in Pakistan. Strategies to Avoid Resistance to Antiviral Drugs

We will determine how best to manage the hepatitis C virus (HCV) epidemic in Pakistan by measuring effectiveness of Pakistan-government sponsored current therapies, emergence of...

Sponsor: Queen Mary University of LondonEnrolling: 250001 location
RECRUITINGNCT06718530

Characterization of Immune Genotypes and Antibody Profiles to Foster the discoVERY of diagnosticbioMARKERS of Liver...

Hepatitis C virus (HCV), which infects more than 185 million people, is a major risk factor. Direct-acting antiviral (DAA) therapy has significantly improved the eradication of...

Sponsor: Centro di Riferimento Oncologico - AvianoEnrolling: 10004 locations
RECRUITINGNCT06544863

Evaluation of Patient Care Support for Cirrhosis and/or Liver Transplants

Cirrhosis is a major challenge in France, with a growing prevalence of 1,500 to 2,500 cases per million inhabitants, and the discovery of 150 to 200 new cases per million...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 30003 locations
RECRUITINGNCT06179498

Partner Navigation Intervention for Hepatitis C Treatment Among Young People Who Inject Drugs

The Partner Navigation Intervention Study is a randomized controlled study (RCT) to assess the efficacy and mechanism of action of the first behavioral intervention to increase...

Sponsor: University of California, San FranciscoEnrolling: 5001 location
RECRUITINGNCT03200379

Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

To determine the treatment efficacy, safety and long-term outcomes of chronic hepatitis C patients receiving directly acting antivirals in Taiwan

Sponsor: Kaohsiung Medical University Chung-Ho Memorial HospitalEnrolling: 1500001 location
RECRUITINGPhase 1NCT06062966

The Effects of IL-1 Blockade on Inotrope Sensitivity in Patients With Heart Failure (AID-HEART)

End-stage heart failure (HF) is a progressive illness with a mortality rate similar to most advanced cancers.Roughly 5% of patients with HF have end-stage disease that is...

Sponsor: Virginia Commonwealth UniversityEnrolling: 201 location
RECRUITINGNCT06658782

Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of...

Aim: To use magnetic resonance imaging (MRI) scans without contrast to help improve diagnosis of liver cancer in people who are at increased risk of developing liver cancer....

Sponsor: University of OxfordEnrolling: 3002 locations
RECRUITINGNCT05870969

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese...

The goal of this study is to evaluate whether the standardized liver cancer risk stratification management can effectively improve the early diagnosis rate of liver cancer in the...

Sponsor: Ruijin HospitalEnrolling: 200001 location
RECRUITINGNCT06155006

Adult Screening for Hepatitis c and Linkage to Treatment in Hospitals in Colombia

Introduction: Hepatitis C virus infection is a major cause of chronic hepatitis, cirrhosis, and liver cancer. The risk of developing cirrhosis for people with chronic infection...

Sponsor: Asociación Colombiana de HepatologíaEnrolling: 256692 locations
RECRUITINGNCT04162938

Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum

The investigators will conduct a randomized controlled clinical trial study in an urban emergency department in Baltimore to determine the impact of an educational app which is...

Sponsor: Johns Hopkins UniversityEnrolling: 3081 location
RECRUITINGNCT07170748

Clinical Performance Evaluation of MagIA IVD-MD Multiplex Testing (HIV/HBV/HCV/Syphilis)

Performance study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA H3S (a Multiplex Point-of-Care test for the combined detection of Human...

Sponsor: MagIA DiagnosticsEnrolling: 29502 locations
RECRUITINGPhase 3NCT07037277

C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV

The purpose of this study is to compare the efficacy and safety of BEM/RZR to SOF/VEL in adults with chronic HCV.

Sponsor: Atea Pharmaceuticals, Inc.Enrolling: 88020 locations
RECRUITINGNCT06082336

Prospective Clinical Performance Evaluation of the In-Vitro Diagnostics Medical Device MaGIA IBC for the CombIned...

Prospective, cross-sectional, adaptative study to evaluate the clinical performance of the In-Vitro Diagnostics Medical Device MagIA IBC (a Multiplex Point-of-Care Test for the...

Sponsor: MagIA DiagnosticsEnrolling: 2522 locations
RECRUITINGPhase 2NCT05832229

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

This is a double-blind, phase 2 study to evaluate safety and efficacy of rosuvastatin in comparison to placebo after 2 years in patients with compensated cirrhosis.

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 25613 locations
RECRUITINGNCT02647879

Treatment as Prevention for Hepatitis C in Iceland

The main aim of this study is to test in the Icelandic population the hypothesis that a nationwide treatment program which offers effective treatment to all known cases of...

Sponsor: Landspitali University HospitalEnrolling: 10001 location
RECRUITINGNCT05368974

The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry

Clinical interventions to reduce the risk of vertical transmission of hepatitis C virus (HCV) infection from mother to infant are highly limited. Direct-acting antiviral (DAA)...

Sponsor: The Task Force for Global HealthEnrolling: 1001 location
RECRUITINGNCT06745895

Multilevel Action Toward Colorectal Cancer and Hepatitis C Education and Screening

This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC...

Sponsor: H. Lee Moffitt Cancer Center and Research InstituteEnrolling: 3501 location
RECRUITINGNCT07095192

Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada

The SCALE-POCT study is a national initiative designed to provide robust evidence for scaling up point-of-care hepatitis C testing for key populations. The study seeks to map...

Sponsor: McGill UniversityEnrolling: 30012 locations
RECRUITINGPhase 2 / Phase 3NCT05637879

Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder

A double-blind randomized placebo-controlled trial to further investigate glecaprevir/pibrentasvir (GLE/PIB), a direct acting antiviral (DAA) that has been associated with...

Sponsor: White River Junction Veterans Affairs Medical CenterEnrolling: 921 location
RECRUITINGNCT05653232

Prophylaxis With Direct-acting Antivirals for Kidney Transplantation From HCV-Infected Donors to Uninfected Recipients

This study is being done to find out the best time to start medication for Hepatitis C Virus (HCV) in HCV-negative recipients of HCV-positive (HCV D+/R-) kidney transplants....

Sponsor: Johns Hopkins UniversityEnrolling: 1209 locations
RECRUITINGNCT06263829

HCV Tappt Adherence Study

The goal of this non-inferiority clinical trial is to evaluate the efficacy of Tappt, a novel digital medication companion solution, among individuals with hepatitis C virus (HCV)...

Sponsor: University of Illinois at ChicagoEnrolling: 301 location
RECRUITINGNCT06409169

DBS TaT in Peer-assisted Telemedicine for Hepatitis C

The purpose of this study is to compare the rate of treatment initiation achieved by peer-assisted telemedicine contingent on phlebotomy (usual care) versus that achieved with a...

Sponsor: Oregon Health and Science UniversityEnrolling: 1411 location
RECRUITINGNCT06904820

Acceptability and Feasibility of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users and...

The "Scanvir" concept aims to achieve barriers to HCV screening and treating of marginalized patients. The concept is applicable to other various populations and territories and...

Sponsor: University Hospital, LimogesEnrolling: 23001 location
RECRUITINGNCT05968573

Persuasive Health Communication Intervention for HIV/HCV

A major impediment to emergency department (ED)-based HIV/HCV screening success is that often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In...

Sponsor: Icahn School of Medicine at Mount SinaiEnrolling: 20001 location
RECRUITINGPhase 4NCT05140941

Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy

This is a multicenter, single arm study of Sofosbuvir/Velpatasvir (SOF/VEL) for treatment of chronic hepatitis C infection during pregnancy. Treatment will be initiated during the...

Sponsor: Catherine Anne ChappellEnrolling: 1009 locations
RECRUITINGNCT03135886

Project I Test: Implementing HIV Testing in Opioid Treatment Programs

This study will test two active evidence-based "practice coaching" (PC) interventions to improve opioid treatment programs' (OTPs') provision and sustained implementation of...

Sponsor: Columbia UniversityEnrolling: 4181 location
RECRUITINGNCT01280825

The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing

The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that...

Sponsor: University of ChicagoEnrolling: 12001 location
RECRUITINGNCT06928259

Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV

Background: Currently used direct-acting antivirals (DAA) share pharmacokinetic pathways with many comedications commonly used in patients with chronic hepatitis C virus (HCV)...

Sponsor: University of SevilleEnrolling: 7284 locations
RECRUITINGNCT04493385

The Hepatitis C Transplant Collaborative

In this study we seek to test the hypothesis that safety and clinical outcomes after cardiac transplantation utilizing HCV NAT+ donor organs as currently performed are acceptable.

Sponsor: Baylor Research InstituteEnrolling: 5001 location
RECRUITINGNCT06180590

The Efficacy of Vosevi in Treating DAA-experienced Patients

Hepatitis C virus (HCV) infection remains a significant health problem in our country. The World Health Organization estimated that 71 million people worldwide had chronic HCV...

Sponsor: The Third Affiliated Hospital of Guangzhou Medical UniversityEnrolling: 2001 location
RECRUITINGNCT07433985

California MEPS Hub

The California Hub for HIV/SUD Prevention Research with Reentry Populations addresses the question: "Can the evidence-based MEPS intervention be adapted and implemented at a range...

Sponsor: University of California, Los AngelesEnrolling: 3183 locations
RECRUITINGNCT06870019

Hepatitis C Tracker Study

The goal of this study is to determine if GPS tracking can enhance adherence to hepatitis C treatment among patients diagnosed with hepatitis C infection who are also experiencing...

Sponsor: University of Southern CaliforniaEnrolling: 1242 locations
RECRUITINGNCT07487623

Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to...

The purpose of this clinical trial is to evaluate whether a nutritional supplement containing resveratrol, quercetin, taurine, inulin, and whey protein improves biochemical and...

Sponsor: University of GuadalajaraEnrolling: 262 locations
RECRUITINGPhase 2NCT03383419

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart...

This phase II, multi-center, open-label study will evaluate the safety and efficacy of utilizing HCV-positive donors for heart transplant in HCV-negative recipients treated with...

Sponsor: Baylor Research InstituteEnrolling: 153 locations
RECRUITINGPhase 3NCT03770936

Effect of Some Drugs on Liver Fibrosis

Effect of Some Drugs on Liver Fibrosis

Sponsor: Sherief Abd-ElsalamEnrolling: 451 location
RECRUITINGNCT02898987

Quality of Care in French HIV Infected Patients

The objective of the Dataids cohort is to continue a long-term, prospective collection of clinical, laboratory and therapeutic data on a large cohort of HIV infected patients...

Sponsor: DatAidsEnrolling: 3000020 locations
RECRUITINGNCT07122219

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons

This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these...

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 5489 locations
RECRUITINGNCT00001971

Evaluation of Patients With Liver Disease

The proposed study aims to evaluate, investigate, and follow-up patients suffering from acute and chronic liver disease. The study will focus on understanding diseases affecting...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 80501 location

Showing 50 of 56 trials.Search all Hepatitis C trials